TP53 and breast carcinoma: Our data showed that TCD induced suppression of cell proliferation, caspase-dependent apoptosis, down-regulation of Akt/NF-κB pathway, up-regulation of p38 MAPK and p53 phosphorylation, inhibition of HDACs expression and increased ROS generation in breast cancer cells.